Gilead’s new HIV prevention drug lenacapavir will ‘change the face of HIV,’ says CEO Daniel O’Day
Gilead's chief executive calls lenacapavir a once in a decade medicine. The HIV treatment could push Gilead stock further up ...
Gilead upgraded by Morgan Stanley on lenacapavir potential
Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...
This HIV drug is hailed as 2024's Discovery of the Year
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
News Medical on MSN2d
HIV drug access remains a major challenge despite promising trial results
Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these ...
‘Pivotal step’: University of Utah biochemist’s HIV research contributes to Science’s ‘Breakthrough of the Year’
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
HIV in 2025: 'There Is Hope for the Future,' Say Disease Experts
Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...
Armed robbery in Revesby7d
WHO Unveils New Lenacapavir, HIV Testing Guidelines
WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...
MIT Technology Review9d
Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
HIV drug lenacapavir is a breakthrough in treating AIDS
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
Glassman: How Trump can meet his goal of ending AIDS
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
Managed Healthcare Executive5d
WHO to Develop Lenacapavir and HIV Testing Guidelines
A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...
Opinion
2024 was a good year for medical progress. But that alone won’t save us.
This year we saw more examples of the destructive effort to undermine abortion as a health service. But overreach into health practices was not limited to abortion care.